Dow Up 0.76% Nasdaq Up 0.69%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
1.62 Up 0.09(5.88%) Oct 24, 4:00PM EDT
|After Hours : 1.62 0.00 (0.00%) Oct 24, 7:49PM EDT
Prev Close:1.53
Open:1.53
Bid:N/A
Ask:2.09 x 3000
1y Target Est:4.50
Beta:4.03
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.52 - 1.63
52wk Range:1.10 - 2.14
Volume:5,099,105
Avg Vol (3m):1,685,590
Market Cap:425.87M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for DVAX

Comparison

Symbol% ChgMkt Cap
DVAXUp 5.88%425.87M
GSKUp 0.95%109.99B
MRKUp 1.73%166.18B
RHHBYDown 0.19%248.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback